Citi XPeng · XPEV

Citi Lowers XPeng Price Target to $22.50

1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$22.50
from $25.60 (−12%)
Upside
+120%
XPEV at $10.24 today
Citi and XPeng logos

What the analyst said

Citi analyst Jeff Chung lowered the price target on XPeng (NYSE: XPEV) to $22.50 (from $25.60) while maintaining a Buy rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $10.24. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $22.50 target is 41% above the median, the highest on the Street.

Since the note XPEV has moved −38% (from $16.45). 12-month window: day 163 of 365, closes on May 28, 2027.

Track record

This callOpen: XPEV has not reached $22.50 yet. This 12-month target is scored on May 28, 2027.

Firm track recordCiti: 88% of its 41 targets at least a year old were reached within 12 months (#3 of 26 firms). Accuracy ranking →

Share

Other analysts on XPeng

JP MorganHold Cut price target −13%, kept rating Oct 26 $10from $11.50 CLSABuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target −11%, kept rating Oct 23 $16from $18 JP MorganHold Downgraded Sep 30 HK$45
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.